Outcome after treatment for solitary plasmacytoma (selected studies).
| Series . | No. of Patients . | Radiotherapy Dose (Gy) . | 10-Year DFS (%) . | OS (Yrs) . | 10-Year OS (%) . |
|---|---|---|---|---|---|
| Abbreviations: DFS, disease-free survival; OS, overall survival. | |||||
| Solitary bone plasmacytoma (SBP) | |||||
| Wilder6 | 60 | 30–70 | 38 | 11 | – |
| Frassica10 | 46 | < 12–70 | 25 | 9.3 | – |
| Tsang8 | 32 | < 30–50 | 36 | 10 | – |
| Bolek15 | 27 | 28.3–60 | 46 | 10 | – |
| Extramedullary plasmacytoma (EMP) | |||||
| Galieni22 | 46 | 40–75 | 78 | – | 80 |
| Liebross17 | 22 | 40–60 | 56 | – | 50 |
| Brinch23 | 18 | 28–60 | 80 | – | 76 |
| Chao16 | 16 | 40–50.4 | 75 | – | 54 |
| Tsang8 | 14 | < 30–50 | 84 | – | 65 |
| Holland14 | 14 | 16.11–62 | 64 | – | NA |
| Series . | No. of Patients . | Radiotherapy Dose (Gy) . | 10-Year DFS (%) . | OS (Yrs) . | 10-Year OS (%) . |
|---|---|---|---|---|---|
| Abbreviations: DFS, disease-free survival; OS, overall survival. | |||||
| Solitary bone plasmacytoma (SBP) | |||||
| Wilder6 | 60 | 30–70 | 38 | 11 | – |
| Frassica10 | 46 | < 12–70 | 25 | 9.3 | – |
| Tsang8 | 32 | < 30–50 | 36 | 10 | – |
| Bolek15 | 27 | 28.3–60 | 46 | 10 | – |
| Extramedullary plasmacytoma (EMP) | |||||
| Galieni22 | 46 | 40–75 | 78 | – | 80 |
| Liebross17 | 22 | 40–60 | 56 | – | 50 |
| Brinch23 | 18 | 28–60 | 80 | – | 76 |
| Chao16 | 16 | 40–50.4 | 75 | – | 54 |
| Tsang8 | 14 | < 30–50 | 84 | – | 65 |
| Holland14 | 14 | 16.11–62 | 64 | – | NA |